KPNA2 is a promising biomarker candidate for esophageal squamous cell carcinoma and correlates with cell proliferation

Oncology Reports

Volumn 32, Issue 4, 2014, Pages 1631-1637

  Ma, Shouzhi ^a   Zhao, Xiaohang ^a  

^a CANCER HOSPITAL   (China)

Author keywords

Cell cycle; Esophageal squamous cell carcinoma; KPNA2; Proliferation; Tumor biomarkers

Indexed keywords

KARYOPHERIN ALPHA; KARYOPHERIN ALPHA 2; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG; KPNA2 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER INHIBITION; CELL FRACTIONATION; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL CANCER CELL LINE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING; ESOPHAGUS TUMOR; GENE SILENCING; GENETICS; METABOLISM; MIDDLE AGED; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ADULT; AGED; ALPHA KARYOPHERINS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 84923068568     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3381     Document Type: Article

References (32)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Wang GQ, Abnet CC, Shen Q, Lewin KJ, Sun XD, Roth MJ, Qiao YL, Mark SD, Dong ZW, Taylor PR and Dawsey SM: Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population. Gut 54: 187-192, 2005. (Pubitemid 40139230)
3. Kelley JB, Talley AM, Spencer A, Gioeli D and Paschal BM: Karyopherin α7 (KPNA7), a divergent member of the importin α family of nuclear import receptors. BMC Cell Biol 11: 63, 2010.
4. Stewart M: Molecular mechanism of the nuclear protein import cycle. Nat Rev Mol Cell Biol 8: 195-208, 2007.
5. Goldfarb DS, Corbett AH, Mason DA, Harreman MT and Adam SA: Importin α: a multipurpose nuclear-transport receptor. Trends Cell Biol 14: 505-514, 2004.
6. Dahl E, Kristiansen G, Gottlob K, Klaman I, Ebner E, Hinzmann B, Hermann K, Pilarsky C, Dürst M, Klinkhammer-Schalke M, Blaszyk H, Knuechel R, Hartmann A, Rosenthal A and Wild PJ: Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin α2 as a potential novel prognostic marker in breast cancer. Clin Cancer Res 12: 3950-3960, 2006. (Pubitemid 44078080)
7. Dankof A, Fritzsche FR, Dahl E, Pahl S, Wild P, Dietel M, Hartmann A and Kristiansen G: KPNA2 protein expression in invasive breast carcinoma and matched peritumoral ductal carcinoma in situ. Virchows Arch 451: 877-881, 2007. (Pubitemid 350060752)
8. Gluz O, Wild P, Meiler R, Diallo-Danebrock R, Ting E, Mohrmann S, Schuett G, Dahl E, Fuchs T, Herr A, Gaumann A, Frick M, Poremba C, Nitz UA and Hartmann A: Nuclear karyopherin α2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity. Int J Cancer 123: 1433-1438, 2008.
9. Zheng M, Tang L, Huang L, Ding H, Liao WT, Zeng MS and Wang HY: Overexpression of karyopherin-2 in epithelial ovarian cancer and correlation with poor prognosis. Obstet Gynecol 116: 884-891, 2010.
10. Winnepenninckx V1, Lazar V, Michiels S, Dessen P, Stas M, Alonso SR, Avril MF, Ortiz Romero PL, Robert T, Balacescu O, Eggermont AM, Lenoir G, Sarasin A, Tursz T, van den Oord JJ, Spatz A; Melanoma Group of the European Organization for Research and Treatment of Cancer: Gene expression profiling of primary cutaneous melanoma and clinical outcome. J Natl Cancer Inst 98: 472-482, 2006.
11. van der Watt PJ, Maske CP, Hendricks DT, Parker MI, Denny L, Govender D, Birrer MJ and Leaner VD: The Karyopherin proteins, Crm1 and Karyopherin β1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation. Int J Cancer 124: 1829-1840, 2009.
12. Wang CI, Wang CL, Wang CW, Chen CD, Wu CC, Liang Y, Tsai YH, Chang YS, Yu JS and Yu CJ: Importin subunit alpha-2 is identified as a potential biomarker for non-small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome. Int J Cancer 128: 2364-2372, 2011.
13. Gousias K, Becker AJ, Simon M and Niehusmann P: Nuclear karyopherin a2: a novel biomarker for infiltrative astrocytomas. J Neurooncol 109: 545-553, 2012.
14. Mortezavi A, Hermanns T, Seifert HH, Baumgartner MK, Provenzano M, Sulser T, Burger M, Montani M, Ikenberg K, Hofstädter F, Hartmann A, Jaggi R, Moch H, Kristiansen G and Wild PJ: KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomy. Clin Cancer Res 17: 1111-1121, 2011.
15. Yoshitake K, Tanaka S, Mogushi K, Aihara A, Murakata A, Matsumura S, Mitsunori Y, Yasen M, Ban D, Noguchi N, Irie T, Kudo A, Nakamura N, Tanaka H and Arii S: Importin-α1 as a novel prognostic target for hepatocellular carcinoma. Ann Surg Oncol 18: 2093-2103, 2011.
16. Jensen JB1, Munksgaard PP, Sørensen CM, Fristrup N, Birkenkamp-Demtroder K, Ulhøi BP, Jensen KM, Ørntoft TF and Dyrskjøt L: High expression of karyopherin-α2 defines poor prognosis in non-muscle-invasive bladder cancer and in patients with invasive bladder cancer undergoing radical cystectomy. Eur Urol 59: 841-848, 2011.
17. Sakai M, Sohda M, Miyazaki T, Suzuki S, Sano A, Tanaka N, Inose T, Nakajima M, Kato H and Kuwano H: Significance of karyopherin- α 2 (KPNA2) expression in esophageal squamous cell carcinoma. Anticancer Res 30: 851-856, 2010.
18. Sun Y, Mi W, Cai J, Ying W, Liu F, Lu H, Qiao Y, Jia W, Bi X, Lu N, Liu S, Qian X and Zhao X: Quantitative proteomic signature of liver cancer cells: tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carcinoma. J Proteome Res 7: 3847-3859, 2008.
19. Xu Y, Zhou L, Huang J, Liu F, Yu J, Zhan Q, Zhang L and Zhao X: Role of Smac in determining the chemotherapeutic response of esophageal squamous cell carcinoma. Clin Cancer Res 17: 5412-5422, 2011.
20. van der Watt PJ, Ngarande E and Leaner VD: Overexpression of Kpnß1 and Kpnα2 importin proteins in cancer derives from deregulated E2F activity. PLoS One 6: e27723, 2011.
21. Wang CI, Chien KY, Wang CL, Liu HP, Cheng CC, Chang YS, Yu JS and Yu CJ: Quantitative proteomics reveals regulation of karyopherin subunit alpha-2 (KPNA2) and its potential novel cargo proteins in nonsmall cell lung cancer. Mol Cell Proteomics 11: 1105-1122, 2012.
22. Ishida S, Huang E, Zuzan H, Spang R, Leone G, West M and Nevins JR: Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Mol Cell Biol 21: 4684-4699, 2001. (Pubitemid 32588250)
23. Zhu W, Giangrande PH and Nevins JR: E2Fs link the control of G1/S and G2/M transcription. EMBO J 23: 4615-4626, 2004. (Pubitemid 39657861)
24. Dong QM, Zhang JQ, Li Q, Bracher JC, Hendricks DT and Zhao XH: Clinical significance of serum expression of GROβ in esophageal squamous cell carcinoma. World J Gastroenterol 17: 2658-2662, 2011.
25. Quensel C, Friedrich B, Sommer T, Hartmann E and Kohler M: In vivo analysis of importin α proteins reveals cellular proliferation inhibition and substrate specificity. Mol Cell Biol 24: 10246-10255, 2004. (Pubitemid 39507863)
26. Huang L, Wang HY, Li JD, Wang JH, Zhou Y, Luo RZ, Yun JP, Zhang Y, Jia WH and Zheng M: KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a. Cell Death Dis 4: e745, 2013.
27. Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA and Dynlacht BD: E2F integrates cell cycle progression with DNA repair, replication, and G2/M checkpoints. Genes Dev 16: 245-256, 2002. (Pubitemid 34075816)
28. Zannini L, Lecis D, Lisanti S, Benetti R, Buscemi G, Schneider C and Delia D: Karyopherin-α2 protein interacts with Chk2 and contributes to its nuclear import. J Biol Chem 278: 42346-42351, 2003. (Pubitemid 37310504)
29. Narod SA and Foulkes WD: BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 4: 665-676, 2004. (Pubitemid 39215065)
30. Tseng SF, Chang CY, Wu KJ and Teng SC: Importin KPNA2 is required for proper nuclear localization and multiple functions of NBS1. J Biol Chem 280: 39594-39600, 2005.
31. Sandrock K, Bielek H, Schradi K, Schmidt G and Klugbauer N: The nuclear import of the small GTPase Rac1 is mediated by the direct interaction with karyopherin α2. Traffic 11: 198-209, 2010.
32. Ebihara Y, Miyamoto M, Shichinohe T, Kawarada Y, Cho Y, Fukunaga A, Murakami S, Uehara H, Kaneko H, Hashimoto H, Murakami Y, Itoh T, Okushiba S, Kondo S and Katoh H: Overexpression of E2F-1 in esophageal squamous cell carcinoma correlates with tumor progression. Dis Esophagus 17: 150-154, 2004. (Pubitemid 39076937)